News
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from April 22 to April 25, 2025
-
-
-
-
-
-
PRESS RELEASE
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Champions Oncology granted license for radioactive materials in preclinical studies, enhancing capabilities in radiotherapeutics development. CEO Ronnie Morris highlights the importance of this milestone -
-